Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Takeshi Sano"'
Autor:
Shusuke Akamatsu, Hideaki Takada, Ryoichi Saito, Takayuki Goto, Akihiro Hamada, Toru Sakatani, Takeshi Sano, Yuki Kita, Kei Mizuno, Keiyu Matsumoto, Osamu Ogawa, Kenji Nakamura, Takashi Kobayashi, Tatsuaki Tsuruyama, Kaoru Murakami
Publikováno v:
Cancer Science
Overcoming cisplatin (CDDP) resistance is a major issue in urothelial cancer (UC), in which CDDP‐based chemotherapy is the first‐line treatment. WEE1, a G2/M checkpoint kinase, confers chemoresistance in response to genotoxic agents. However, the
Autor:
Shusuke Haruta, Shigeyuki Tamura, Masakazu Takagi, Masanori Tokunaga, Mitsuru Sasako, Hiroshi Katayama, Takaki Yoshikawa, Kenichi Nakamura, Hitoshi Katai, Makoto Yamada, Narikazu Boku, Takeo Fukagawa, Yuya Sato, Tsunehiro Yoshimura, Junki Mizusawa, Masanori Terashima, Takeshi Sano
Publikováno v:
European Journal of Surgical Oncology. 46:1074-1079
Background Neoadjuvant chemotherapy (NAC) is increasingly used for resectable locally advanced gastric cancer (LAGC). JCOG1302A investigated the diagnostic criteria of LAGC patients with cT3–4/N1–3 to minimize contamination of pathological stage
Autor:
Satoshi Ida, Koshi Kumagai, Rie Makuuchi, Naoki Hiki, Takeshi Sano, Yosuke Kano, Souya Nunobe, Manabu Ohashi
Publikováno v:
Gastric Cancer. 23:927-936
Whether splenectomy for splenic hilar lymph node (No. 10) dissection in type 4 gastric cancer involving the greater curvature is necessary is not established. Patients with type 4 gastric cancer often experience peritoneal relapse, despite curative s
Autor:
Yusuke Horiuchi, Toshiyuki Yoshio, Manabu Ohashi, Tomohiro Tsuchida, Naoki Ishizuka, Toshiaki Hirasawa, Souya Nunobe, Koshi Kumagai, Takeshi Sano, Noriko Yamamoto, Akiyoshi Ishiyama, Satoshi Ida, Junko Fujisaki, Shoichi Yoshimizu
Publikováno v:
Gastric Cancer. 23:285-292
Based on Japanese guidelines for endoscopic submucosal dissection (ESD) in undifferentiated-type early gastric cancer (UD-EGC), UD-predominant mixed-type (M-UD) EGC is considered high risk for lymph node metastasis (LNM). However, differences in LNM
Autor:
Satoshi Ida, Itaru Yasufuku, Koshi Kumagai, Souya Nunobe, Takeshi Sano, Manabu Ohashi, Naoki Hiki
Publikováno v:
Gastric Cancer. 23:319-327
The long-term outcomes of type 4 and large type 3 gastric cancer patients with positive peritoneal lavage cytology (CY1) remain unsatisfying. We evaluated our treatment strategy of conversion therapy for CY1 patients without peritoneal dissemination
Autor:
Naoki Ishizuka, Manabu Ohashi, Takeshi Sano, Naoki Hiki, Souya Nunobe, Motonari Ri, Koshi Kumagai, Satoshi Ida
Publikováno v:
Gastric Cancer. 22:1053-1059
Although duodenal stump leakage (DSL) is a relatively rare complication after gastrectomy with Roux-en-Y (R-Y) reconstruction, it is difficult to treat and can be fatal. We investigated the impact of duodenal stump reinforcement on DSL after laparosc
Autor:
Takeshi Sano, Souya Nunobe, Manabu Ohashi, Yoshiaki Shoji, Satoshi Ida, Naoki Hiki, Koshi Kumagai
Publikováno v:
Gastric Cancer. 22:1036-1043
Double-flap technique (DFT) has received increased attention as an anastomotic procedure preventing reflux esophagitis after laparoscopic proximal gastrectomy (LPG) for upper-third gastric cancer. However, incidence of anastomotic stricture still rem
Autor:
Naoki Hiki, Koshi Kumagai, Yosuke Kano, Takeshi Sano, Satoshi Ida, Souya Nunobe, Manabu Ohashi
Publikováno v:
Gastric Cancer. 22:1060-1068
The upper gastric body is of particular interest in relation to gastrectomy because this area includes a border; that is, both distal and proximal gastrectomy for early gastric cancer can involve this area. Laparoscopic subtotal gastrectomy (LsTG) is
Autor:
Toshiaki Hirasawa, Noriko Yamamoto, Takeshi Sano, Tomo Osako, Akiyoshi Ishiyama, Toshiyuki Yoshio, Satoshi Kamiya, Satoshi Ida, Yusuke Horiuchi, Koshi Kumagai, Junko Fujisaki, Naoki Hiki, Yoshiaki Shoji, Manabu Ohashi, Souya Nunobe, Shoichi Yoshimizu
Publikováno v:
Gastric Cancer. 22:873-880
The double-tracer method has been established for sentinel node (SN) mapping in gastric cancer surgery. However, there remain several unresolved issues that prevent its widespread use in clinical practice. In this study, we aimed to demonstrate the f
Autor:
Yasunori Nishida, Tomonori Mizutani, Hiroshi Yabusaki, Mitsuru Sasako, Kazuya Yamaguchi, Narikazu Boku, Takeshi Sano, Masanori Terashima, Seiji Ito, Junki Mizusawa, Takaki Yoshikawa, Kazuhiro Yoshida
Publikováno v:
Japanese Journal of Clinical Oncology. 48:1101-1104
Adjuvant chemotherapy with S-1 is a standard treatment for patients with stage II/III gastric cancer after D2 gastrectomy; however, this is not uniformly applicable in older patients. The Stomach Cancer Study Group of the Japan Clinical Oncology Grou